National Bank Of Canada Sarepta Therapeutics, Inc. Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 415 shares of SRPT stock, worth $40,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
415
Previous 387
7.24%
Holding current value
$40,823
Previous $48,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SRPT
# of Institutions
535Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.02 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$894 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$856 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$426 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$400 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $8.61B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...